NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation
AimsAntithrombotic therapy after transcatheter aortic valve implantation (TAVI) is highly controversial and guideline recommendations are not evidence based. We assessed efficacy and safety of non-vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with concomitant indications for...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 April 2018
|
| In: |
Clinical research in cardiology
Year: 2018, Jahrgang: 107, Heft: 9, Pages: 799-806 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-018-1247-x |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1007/s00392-018-1247-x
|
| Verfasserangaben: | Nicolas A. Geis, Christina Kiriakou, Emmanuel Chorianopoulos, Lorenz Uhlmann, Hugo A. Katus, Raffi Bekeredjian |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1670509184 | ||
| 003 | DE-627 | ||
| 005 | 20220816202331.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190802s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00392-018-1247-x |2 doi | |
| 035 | |a (DE-627)1670509184 | ||
| 035 | |a (DE-599)KXP1670509184 | ||
| 035 | |a (OCoLC)1341235284 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Geis, Nicolas |d 1980- |e VerfasserIn |0 (DE-588)138513988 |0 (DE-627)696681854 |0 (DE-576)307885313 |4 aut | |
| 245 | 1 | 0 | |a NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation |c Nicolas A. Geis, Christina Kiriakou, Emmanuel Chorianopoulos, Lorenz Uhlmann, Hugo A. Katus, Raffi Bekeredjian |
| 264 | 1 | |c 11 April 2018 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.08.2019 | ||
| 520 | |a AimsAntithrombotic therapy after transcatheter aortic valve implantation (TAVI) is highly controversial and guideline recommendations are not evidence based. We assessed efficacy and safety of non-vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with concomitant indications for OAC undergoing TAVI.MethodsAmong more than 1300 TAVI patients since 2008, 154 patients were identified who received postinterventional NOAC monotherapy. Outcomes were compared to 172 patients treated with vitamin K antagonist (VKA) monotherapy. Thromboembolic as well as bleeding complications were analysed for 6 months after TAVI.ResultsDespite high CHA2DS2-Vasc (4.6 ± 1.2), HEMORR2HAGES (4.7 ± 1.9) and HASBLED (2.7 ± 0.8) scores only three major/life-threatening bleedings and four thromboembolic events occurred after NOAC therapy had been initiated post-TAVI. 12 patients (7.8%) died within 6 months after the procedure. Compared to patients being treated with VKA monotherapy, analysis of a combined end-point of post-procedural death, stroke, embolism and severe bleeding revealed no significant differences (17/154 vs. 14/172; p = 0.45).ConclusionsThe results of this study suggest that NOAC therapy without additional antiplatelet treatment is effective and safe in patients with concomitant indications for OAC undergoing TAVI. | ||
| 650 | 4 | |a Anticoagulation | |
| 650 | 4 | |a Antithrombotic therapy | |
| 650 | 4 | |a Atrial fibrillation | |
| 650 | 4 | |a NOAC | |
| 650 | 4 | |a Transcatheter aortic valve implantation | |
| 650 | 4 | |a Transcatheter aortic valve replacement | |
| 700 | 1 | |a Kiriakou, Christina |e VerfasserIn |0 (DE-588)1156805929 |0 (DE-627)1019739959 |0 (DE-576)502445238 |4 aut | |
| 700 | 1 | |a Chorianopoulos, Emmanuel |d 1974- |e VerfasserIn |0 (DE-588)122373332 |0 (DE-627)705883302 |0 (DE-576)293242550 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Bekeredjian, Raffi |d 1972- |e VerfasserIn |0 (DE-588)122088271 |0 (DE-627)705767930 |0 (DE-576)293085781 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical research in cardiology |d Berlin : Springer, 2006 |g 107(2018), 9, Seite 799-806 |h Online-Ressource |w (DE-627)506287343 |w (DE-600)2218331-0 |w (DE-576)251097692 |x 1861-0692 |7 nnas |a NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation |
| 773 | 1 | 8 | |g volume:107 |g year:2018 |g number:9 |g pages:799-806 |g extent:8 |a NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00392-018-1247-x |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190802 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 122088271 |a Bekeredjian, Raffi |m 122088271:Bekeredjian, Raffi |d 910000 |d 910100 |e 910000PB122088271 |e 910100PB122088271 |k 0/910000/ |k 1/910000/910100/ |p 6 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 122373332 |a Chorianopoulos, Emmanuel |m 122373332:Chorianopoulos, Emmanuel |d 50000 |e 50000PC122373332 |k 0/50000/ |p 3 | ||
| 998 | |g 1156805929 |a Kiriakou, Christina |m 1156805929:Kiriakou, Christina |d 910000 |d 910100 |e 910000PK1156805929 |e 910100PK1156805929 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 138513988 |a Geis, Nicolas |m 138513988:Geis, Nicolas |d 910000 |d 910100 |e 910000PG138513988 |e 910100PG138513988 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1670509184 |e 3503300376 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Geis, Nicolas","family":"Geis","role":"aut","given":"Nicolas"},{"role":"aut","given":"Christina","family":"Kiriakou","display":"Kiriakou, Christina"},{"family":"Chorianopoulos","display":"Chorianopoulos, Emmanuel","role":"aut","given":"Emmanuel"},{"display":"Katus, Hugo","family":"Katus","given":"Hugo","role":"aut"},{"role":"aut","given":"Raffi","display":"Bekeredjian, Raffi","family":"Bekeredjian"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 02.08.2019"],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"11 April 2018"}],"title":[{"title":"NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation","title_sort":"NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation"}],"id":{"eki":["1670509184"],"doi":["10.1007/s00392-018-1247-x"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"recId":"506287343","id":{"eki":["506287343"],"zdb":["2218331-0"],"issn":["1861-0692"]},"part":{"volume":"107","extent":"8","issue":"9","text":"107(2018), 9, Seite 799-806","pages":"799-806","year":"2018"},"title":[{"title":"Clinical research in cardiology","title_sort":"Clinical research in cardiology"}],"origin":[{"publisherPlace":"Berlin","publisher":"Springer","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"pubHistory":["95.2006 -"],"disp":"NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantationClinical research in cardiology","type":{"bibl":"periodical","media":"Online-Ressource"}}],"recId":"1670509184","name":{"displayForm":["Nicolas A. Geis, Christina Kiriakou, Emmanuel Chorianopoulos, Lorenz Uhlmann, Hugo A. Katus, Raffi Bekeredjian"]},"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a GEISNICOLANOACMONOTH1120 | ||